Indication
ELIGARD is a prescription drug, given by injection, for the management of advanced
prostate cancer. However, there is no known cure for prostate cancer.
Important Safety Information
ELIGARD should not be used by women, children, or anyone who is allergic to the
drug leuprolide acetate or any of the ingredients of ELIGARD.
ELIGARD, like other drugs in its class, causes a temporary increase in testosterone
during the first week of treatment. Patients may experience worsening of symptoms
or new symptoms during the first weeks of treatment, including bone pain, nerve
damage, blood in the urine, or difficulty urinating. The most common side effects
are hot flashes, injection site pain (including burning and stinging), fatigue,
and testicular atrophy.
Please see and full mixing and administration instructions.
Click here
for information on drug anti-counterfeiting.